Also known as: Mary H. Weiser Food Allergy Center and Michigan Nanotechnology Institute for Medicine and the Biological Sciences
Highest phase reached
Phase 2
First clinical trial
Last known activity
Apr 7, 2021
No events for the selected filters.
Phase 2 (2 own, 0 via acquisition)